Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory T-cell Acute Lymphoblastic Leukaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07244406
What this trial is testing

Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL

Who this might be right for
B-ALL
Hebei Senlang Biotechnology Inc., Ltd. 59
Early research (Phase 1)UnknownNCT06209671
What this trial is testing

INS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic Leukemia

Who this might be right for
Leukemia, B-cell
Beijing Immunochina Medical Science & Technology Co., Ltd. 12
Early research (Phase 1)Study completedNCT00513474
What this trial is testing

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Massachusetts General Hospital 46
Early research (Phase 1)Study completedNCT01094860
What this trial is testing

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT04340167
What this trial is testing

Study of Anti-CD22 CAR-T Cells Treating Leukemia Children

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoblastic Leukemia
Beijing Boren Hospital 14
Not applicableEnded earlyNCT00946283
What this trial is testing

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersLeukemia+7 more
Rutgers, The State University of New Jersey 30
Testing effectiveness (Phase 2)Study completedNCT01326702
What this trial is testing

Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult Solid Neoplasm+35 more
National Cancer Institute (NCI) 43
Early research (Phase 1)Looking for participantsNCT04848064
What this trial is testing

Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

Who this might be right for
Recurrent Adult T-Cell Leukemia/LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaRefractory Adult T-Cell Leukemia/Lymphoma+1 more
John Reneau 12
Early research (Phase 1)Looking for participantsNCT05476770
What this trial is testing

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAMLALL+8 more
Therapeutic Advances in Childhood Leukemia Consortium 54
Very early researchNot Yet RecruitingNCT07696481
What this trial is testing

Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia

Who this might be right for
Relapsed or Refractory Acute LeukemiaRelapsed or Refractory Acute Lymphoblastic LeukemiaRelapsed or Refractory Acute Myeloid Leukemia (AML)
Zhujiang Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT06635330
What this trial is testing

Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL

Who this might be right for
Relapse/Refractory B-cell Acute Lymphoblastic Leukemia
Kara Yakhteh Tajhiz Azma Company 5